Page 6 - Structural Heart Program News Today

Research presented at the American Heart Association’s Scientific Sessions 2023 suggests that current recommendation for vitamin D dosage are not sufficiently high to support optimal heart health.

A single dose of an experimental medication called zilebesiran was safe and effective in lowering blood pressure for 6 month, a study finds.

A clinical trial suggests that a single infusion of a gene-editing therapeutic could help reduce high levels of hereditary LDL-C, or 'bad,' cholesterol.

Researchers report promising results in initial clinical trials on two new drugs that target high cholesterol in different ways at the genetic level

Innovative new treatment option for patients with uncontrolled hypertension now available in the United States 

Researchers say their new study on how cholesterol is absorbed into the body may help pave the way for future treatments that reduce cholesterol levels

Researchers say genetic testing can identify people with a family history of high cholesterol and help them reduce their risk of cardiovascular disease

Innovative new treatment option for patients with uncontrolled hypertension now available in the United StatesPALO ALTO, Calif.--(BUSINESS WIRE)--Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”), today announced the first commercial uses of Recor’s Par...

Researchers say any activity, even sleeping, is better for heart health than prolonged periods of sitting. Experts say there are simple ways to increase the amount of daily activity.

Two separate studies examined the long-term use of marijuana and the impact it may have on the heart. The first study showed that daily cannabis use increases the risk of developing heart failure by 34%. The second study found that older cannabis users are more likely to have a heart attack or other heart event during hospital stays.